Precision Biosensor, Inc.

Research Precision Biosensor, Inc. (335810.KQ) on Bullrun: market cap KRW 32.60B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker335810.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryMedical Devices
CurrencyKRW
Market capKRW 32.60B
Financial periodQ2 2026
RevenueKRW 6.22B
Net income-KRW 1.17B
Free cash flow-KRW 400.68M
Gross margin35.9%

Valuation Snapshot

latest market cap is KRW 32.60B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 32.60B	n/a	n/a	n/a

Dividend history

About Precision Biosensor, Inc.

Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

JPI Healthcare Co.,Ltd. (0010V0.KQ) Shinhung Co., Ltd (004080.KS) Osang Healthcare Co.,Ltd (036220.KQ) HansBiomed Corporation (042520.KQ) JVM Co., Ltd. (054950.KQ) CG MedTech Co.,Ltd. (056090.KQ) Huvitz Co., Ltd. (065510.KQ) Vieworks Co., Ltd. (100120.KQ) Corentec Co., Ltd. (104540.KQ) SD Biosensor, Inc. (137310.KS) Hironic Co., Ltd. (149980.KQ) L&K Biomed Ltd. (156100.KQ)

Frequently asked questions

What is Precision Biosensor, Inc.'s market cap?

Precision Biosensor, Inc.'s market capitalization is KRW 32.60B.